Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR-Guided Ultrasound-Stimulated Microbubbles + Radiation for Breast Cancer
NCT06185972Phase 2Recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jul 2024
- Primary completion
- Feb 2026
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of perflutren lipid microspheres in breast cancer, sponsored by Sunnybrook Health Sciences Centre. Started Jul 2024; status: recruiting.
02
Drugs
perflutren lipid microspheres
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06185972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06185972.